From Molecules to Patients: The Clinical Applications of Translational Bioinformatics
暂无分享,去创建一个
[1] Richard Simon,et al. Implementing personalized cancer genomics in clinical trials , 2013, Nature Reviews Drug Discovery.
[2] Bairong Shen,et al. Translational Bioinformatics for Diagnostic and Prognostic Prediction of Prostate Cancer in the Next-Generation Sequencing Era , 2013, BioMed research international.
[3] Mehmet Koyutürk,et al. Network biology methods integrating biological data for translational science , 2012, Briefings Bioinform..
[4] Emidio Capriotti,et al. Bioinformatics for personal genome interpretation , 2012, Briefings Bioinform..
[5] Leroy Hood,et al. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. , 2004, Journal of proteome research.
[6] Maricel G. Kann,et al. Chapter 4: Protein Interactions and Disease , 2012, PLoS Comput. Biol..
[7] Ju Han Kim. New horizons in translational bioinformatics: TBC 2013 , 2014, BMC Medical Genomics.
[8] L. Lesko. Drug Research and Translational Bioinformatics , 2012, Clinical pharmacology and therapeutics.
[9] Xu Han,et al. Literature Based Drug Interaction Prediction with Clinical Assessment Using Electronic Medical Records: Novel Myopathy Associated Drug Interactions , 2012, PLoS Comput. Biol..
[10] Indra Neil Sarkar,et al. A vector space model approach to identify genetically related diseases , 2012, J. Am. Medical Informatics Assoc..
[11] Y. Joly,et al. Opportunities and Challenges Provided by Cloud Repositories for Bioinformatics‐Enabled Drug Discovery , 2014, Drug development research.
[12] Madeleine Udell,et al. Analyzing Patterns of Drug Use in Clinical Notes for Patient Safety , 2012, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.
[13] Suresh K. Bhavnani,et al. iCircos: visual analytics for translational bioinformatics , 2012, IHI '12.
[14] Ara Darzi,et al. Preparing for precision medicine. , 2012, The New England journal of medicine.
[15] Francisco Azuaje,et al. Drug interaction networks: an introduction to translational and clinical applications. , 2013, Cardiovascular research.
[16] Martin Hofmann-Apitius,et al. Challenges and opportunities for oncology biomarker discovery. , 2013, Drug discovery today.
[17] S. Sudarsanam,et al. Translational biology approach to identify causative factors for rare toxicities in humans and animals. , 2012, Current drug discovery technologies.
[18] M. Khoury,et al. “Drivers” of Translational Cancer Epidemiology in the 21st Century: Needs and Opportunities , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[19] Mark A. Musen,et al. Chapter 9: Analyses Using Disease Ontologies , 2012, PLoS Comput. Biol..
[20] Matthew S. Lebo,et al. A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record , 2013, Genetics in Medicine.
[21] Philip R. O. Payne. Chapter 1: Biomedical Knowledge Integration , 2012, PLoS Comput. Biol..
[22] Christopher G. Chute,et al. Some experiences and opportunities for big data in translational research , 2013, Genetics in Medicine.
[23] P. Sanseau,et al. Computational Drug Repositioning: From Data to Therapeutics , 2013, Clinical pharmacology and therapeutics.
[24] Kip Nalley,et al. Tissue Banking, Bioinformatics, and Electronic Medical Records: The Front-End Requirements for Personalized Medicine , 2013, Journal of oncology.
[25] A. Butte,et al. Translational Bioinformatics: Data‐driven Drug Discovery and Development , 2012, Clinical pharmacology and therapeutics.
[26] Bairong Shen,et al. Translational Biomedical Informatics in the Cloud: Present and Future , 2013, BioMed research international.